Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Verastem Inc has a consensus price target of $15.7 based on the ratings of 11 analysts. The high is $34 issued by Cantor Fitzgerald on July 6, 2023. The low is $5 issued by BTIG on October 5, 2022. The 3 most-recent analyst ratings were released by Guggenheim, HC Wainwright & Co., and RBC Capital on March 24, 2025, March 24, 2025, and March 21, 2025, respectively. With an average price target of $12.67 between Guggenheim, HC Wainwright & Co., and RBC Capital, there's an implied 166.01% upside for Verastem Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
03/24/2025 | Buy Now | 194.01% | Guggenheim | Michael Schmidt53% | $13 → $14 | Maintains | Buy | Get Alert |
03/24/2025 | Buy Now | 110% | HC Wainwright & Co. | Sean Lee65% | $7 → $10 | Maintains | Buy | Get Alert |
03/21/2025 | Buy Now | 194.01% | RBC Capital | Gregory Renza46% | $16 → $14 | Maintains | Outperform | Get Alert |
01/31/2025 | Buy Now | 89% | B. Riley Securities | Kalpit Patel37% | $7 → $9 | Maintains | Buy | Get Alert |
01/24/2025 | Buy Now | — | Guggenheim | Michael Schmidt53% | — | Reiterates | Buy → Buy | Get Alert |
01/07/2025 | Buy Now | 236.01% | RBC Capital | Gregory Renza46% | $13 → $16 | Maintains | Outperform | Get Alert |
12/19/2024 | Buy Now | 89% | Mizuho | Mara Goldstein55% | $7 → $9 | Maintains | Outperform | Get Alert |
12/19/2024 | Buy Now | 47% | HC Wainwright & Co. | Sean Lee65% | $7 → $7 | Reiterates | Buy → Buy | Get Alert |
10/18/2024 | Buy Now | 173.01% | RBC Capital | Gregory Renza46% | $13 → $13 | Reiterates | Outperform → Outperform | Get Alert |
10/18/2024 | Buy Now | — | Cantor Fitzgerald | Pete Stavropoulos40% | — | Reiterates | → Overweight | Get Alert |
10/18/2024 | Buy Now | 47% | HC Wainwright & Co. | Sean Lee65% | $7 → $7 | Reiterates | Buy → Buy | Get Alert |
09/30/2024 | Buy Now | 173.01% | Guggenheim | Michael Schmidt53% | → $13 | Initiates | → Buy | Get Alert |
08/13/2024 | Buy Now | 215.01% | Truist Securities | Srikripa Devarakonda43% | $18 → $15 | Maintains | Buy | Get Alert |
08/12/2024 | Buy Now | 47% | HC Wainwright & Co. | Sean Lee65% | $17.5 → $7 | Maintains | Buy | Get Alert |
08/09/2024 | Buy Now | 173.01% | RBC Capital | Gregory Renza46% | $16 → $13 | Maintains | Outperform | Get Alert |
07/24/2024 | Buy Now | 47% | B. Riley Securities | Kalpit Patel37% | $21 → $7 | Maintains | Buy | Get Alert |
07/08/2024 | Buy Now | 278.01% | Truist Securities | Srikripa Devarakonda43% | $34 → $18 | Maintains | Buy | Get Alert |
05/29/2024 | Buy Now | 320.01% | Alliance Global Partners | Jeff Grampp62% | $34 → $20 | Maintains | Buy | Get Alert |
05/28/2024 | Buy Now | 236.01% | RBC Capital | Gregory Renza46% | $32 → $16 | Maintains | Outperform | Get Alert |
05/28/2024 | Buy Now | 267.51% | HC Wainwright & Co. | Sean Lee65% | $17.5 → $17.5 | Reiterates | Buy → Buy | Get Alert |
05/13/2024 | Buy Now | 267.51% | HC Wainwright & Co. | Sean Lee65% | $17.5 → $17.5 | Reiterates | Buy → Buy | Get Alert |
03/19/2024 | Buy Now | 267.51% | HC Wainwright & Co. | Sean Lee65% | → $17.5 | Reiterates | Buy → Buy | Get Alert |
03/15/2024 | Buy Now | 572.01% | RBC Capital | Gregory Renza46% | $32 → $32 | Reiterates | Outperform → Outperform | Get Alert |
11/21/2023 | Buy Now | 467.01% | BTIG | Justin Zelin41% | → $27 | Assumes | → Buy | Get Alert |
11/15/2023 | Buy Now | 614.02% | Truist Securities | Srikripa Devarakonda43% | $39 → $34 | Maintains | Buy | Get Alert |
09/29/2023 | Buy Now | 341.01% | B. Riley Securities | Kalpit Patel37% | $21 → $21 | Reiterates | Buy → Buy | Get Alert |
09/27/2023 | Buy Now | 341.01% | B. Riley Securities | Kalpit Patel37% | → $21 | Initiates | → Buy | Get Alert |
08/29/2023 | Buy Now | 656.02% | Mizuho | Mara Goldstein55% | → $36 | Reiterates | Buy → Buy | Get Alert |
08/09/2023 | Buy Now | 572.01% | RBC Capital | Gregory Renza46% | $34 → $32 | Maintains | Outperform | Get Alert |
07/11/2023 | Buy Now | 719.02% | Truist Securities | Srikripa Devarakonda43% | $60 → $39 | Maintains | Buy | Get Alert |
07/06/2023 | Buy Now | 614.02% | Cantor Fitzgerald | Alethia Young76% | → $34 | Reiterates | Overweight → Overweight | Get Alert |
07/03/2023 | Buy Now | 614.02% | RBC Capital | Gregory Renza46% | $36 → $34 | Maintains | Outperform | Get Alert |
06/27/2023 | Buy Now | 1160.03% | Truist Securities | Srikripa Devarakonda43% | $60 → $60 | Reiterates | Buy → Buy | Get Alert |
06/23/2023 | Buy Now | 1160.03% | Truist Securities | Srikripa Devarakonda43% | → $60 | Reiterates | Buy → Buy | Get Alert |
06/15/2023 | Buy Now | 656.02% | Mizuho | Mara Goldstein55% | $24 → $36 | Upgrade | Neutral → Buy | Get Alert |
05/10/2023 | Buy Now | -58% | HC Wainwright & Co. | Sean Lee65% | $36 → $24 | Maintains | Buy | Get Alert |
03/30/2023 | Buy Now | -58% | Mizuho | Mara Goldstein55% | → $24 | Initiates | → Neutral | Get Alert |
03/15/2023 | Buy Now | -37% | RBC Capital | Gregory Renza46% | → $36 | Reiterates | → Outperform | Get Alert |
03/15/2023 | Buy Now | -37% | HC Wainwright & Co. | Sean Lee65% | → $36 | Reiterates | → Buy | Get Alert |
11/07/2022 | Buy Now | -37% | HC Wainwright & Co. | Sean Lee65% | $60 → $36 | Maintains | Buy | Get Alert |
10/05/2022 | Buy Now | 5% | BTIG | Robert Hazlett37% | $96 → $60 | Maintains | Buy | Get Alert |
04/14/2022 | Buy Now | 5% | RBC Capital | Gregory Renza46% | → $60 | Initiates | → Outperform | Get Alert |
The latest price target for Verastem (NASDAQ:VSTM) was reported by Guggenheim on March 24, 2025. The analyst firm set a price target for $14.00 expecting VSTM to rise to within 12 months (a possible 194.01% upside). 21 analyst firms have reported ratings in the last year.
The latest analyst rating for Verastem (NASDAQ:VSTM) was provided by Guggenheim, and Verastem maintained their buy rating.
The last upgrade for Verastem Inc happened on June 15, 2023 when Mizuho raised their price target to $36. Mizuho previously had a neutral for Verastem Inc.
There is no last downgrade for Verastem.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Verastem, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Verastem was filed on March 24, 2025 so you should expect the next rating to be made available sometime around March 24, 2026.
While ratings are subjective and will change, the latest Verastem (VSTM) rating was a maintained with a price target of $13.00 to $14.00. The current price Verastem (VSTM) is trading at is $4.76, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.